Sivik Global Healthcare Llc Portfolio Analysis: Top Holdings in Biotech & Healthcare

Sivik Global Healthcare Llc maintains a concentrated portfolio focused entirely on the healthcare sector, holding significant positions in large-cap pharmaceutical companies and biotech ETFs as of June 30, 2026.

By Insiderset.Jul 21, 2026, 1:36 PM
Sivik Global Healthcare Llc Portfolio Analysis: Top Holdings in Biotech & Healthcare

Sivik Global Healthcare Llc stands as a specialized investment entity with a clearly defined focus: investing exclusively within the dynamic healthcare industry. As of June 30, 2026, their portfolio totals $122,722 and is entirely allocated to this sector.

Examining the holdings reveals that Sivik Global Healthcare Llc maintains a concentrated portfolio focused entirely on the healthcare sector, holding significant positions in large-cap pharmaceutical companies and biotech ETFs as of June 30, 2026. The largest position by weight is held in the SPDR S&P Biotech ETF (XBI), accounting for approximately 14.55% of their total portfolio value.

The **SPDR S&P BIOTECH ETF (XBI)** represents a substantial portion of this investment strategy, valued at $19,160 as of June 30, 2026. This position remains unchanged from the previous period according to available data. For detailed information on XBI's holdings and performance, investors can visit Insiderset.

Complementing their significant exposure through the XBI ETF, Sivik Global Healthcare Llc holds substantial shares in established pharmaceutical giants. **JOHNSON&JOHNSON (JNJ)** is valued at $4,889 and accounts for 3.71% of the portfolio. Similarly, **MERCK & CO (MRK)** has a position worth $4,812 or 3.65%. Both JNJ and MRK can be explored in depth on Insiderset and Insiderset.

The portfolio also includes exposure to other notable healthcare companies. **CARDINAL HEALTH (CAH)**, a diversified medical products company, holds $507 worth of shares or 0.38% allocation. The investor maintains positions in CENCORA INC (COR), WATERS CORP (WAT), ELI LILLY & CO (LLY), and VERTEX PHARMACEUTICALS INC. (VRTX) among others, though the latter three are slightly smaller at $4,712 ($3.58%), $4,467 ($3.39%), and $4,149 ($3.15%) respectively.

Notably, all listed holdings show no change in share count from the previous period, indicating a stable approach by Sivik Global Healthcare Llc to managing their portfolio positions. For more details on THERMO FISHER SCIENTIFIC INC. (TMO), visit Insiderset.

For comprehensive data and analysis on Sivik Global Healthcare Llc's investment activities, including their entire portfolio composition, detailed holdings information can be found at Insiderset.